Investors

Investor Relations

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.


In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.

 

INNOVATORS with Jane King – interviewing CEO Glenn Mattes
& Dr. Bill Williams - Professor at Univ. of Texas – Austin


At the NASDAQ Market Site, Nov. 20, 2019

Volume:

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases

Top